Sage Journals: Discover world-class research

Abstract

An adolescent with longstanding HIV infection who was severely immunosuppressed during HIV diagnosis developed cholangiocarcinoma 1.5 years after starting antiretroviral therapy.

Keywords

cholangiocarcinoma adolescence HIV

Get full access to this article

View all access options for this article.

References

Lazardis

, Gores

GJ.

Cholangiocarcinoma.

Gastroenterology 2005; 128: 1655–67.

Charlier

, Lecuit

, Furco

Cholangiocarcinoma in HIV-Infected patients with a history of cholangitis.

J Acquir Immun Defic Syndr 2005; 39: 253–4.

Shaib

, El-Serag

HB.

The epidemiology of cholangiocarcinoma.

Semin Liver Dis 2004; 24: 115–25.

Chen

MF.

Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment.

J Gastroenterol Hepatol 1999; 14: 1144–9.

Shimonishi

, Sasaki

, Nakasuma

Precancerous lesions of intrahepatic cholangiocarcinoma.

J Hepatobiliary Pancreat Surg 2000; 7: 542–50.

Shaib

, El-Serag

, Davila

, Morgan

, McGlynn

KA.

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.

Gastroenterology 2005; 128: 620–6.

Hocqueloux

, Gervais

Cholangiocarcinoma and AIDS-related sclerosing cholangitis.

Ann Intern Med 2000; 132: 1006–7.

Sheikh

, Prindiville

, Sury

, Munn

, Ruebner

BH.

Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review.

Am J Gastroenterol 2000; 95: 2364–71.

Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection

Abstract

Keywords

Get full access to this article

References